№ files_lp_4_process_3_121534
File format: docx Character count: 23445 File size: 109 KB
Structured clinical guidance for registered healthcare professionals to supply and manage progestogen-only contraceptive pills in line with national PGD standards and organisational authorisations.
Year: 2025
Region / Location: [location/service/organisation]
Document Type: Patient Group Direction (PGD)
Issuing Organization: College of Sexual and Reproductive Healthcare (CoSRH)
Authors / Contributors: Alison Crompton, Bola Sotubo, Carmel Lloyd, Dr Cindy Farmer, Clare Livingstone, Dipti Patel, Emma Anderson, Heather Randle, Julia Hogan, Kate Devonport, Kirsty Armstrong, Lisa Knight, Michelle Jenkins, Portia Jackson, Rachel Logan, Tanya Lane, Jo Jenkins, Kieran Reynolds, Rosie Furner, Sandra Wolper
Intended Users: Registered healthcare professionals authorized to operate under the PGD
Implementation Date: 1st April 2026
Review Date: 1st September 2028
Expiry Date: 31st March 2029
Version History: Version 1 (April 2020), Version 1.1 (November 2020), Version 2.0 (April 2023), Version 2.1 (April 2024), Version 2.2 (April 2025), Version 2.3 (July 2025), Version 3.0 (October 2025)
Regulatory Reference: Human Medicines Regulation 2012, Schedule 16 Part 4
Approval: College of Sexual and Reproductive Healthcare (CoSRH), January 2026
Supporting Groups: Reproductive Health PGDs Short Life Working Group (SLWG)
Contextual Scope: Contraceptive medicine administration and patient safety guidelines
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Patient Group Direction for the supply of nitrofurantoin capsules/tablets for the treatment of Urinary Tract Infection (UTI) in [location/service/organisation]
Version: 2.0
Year: 2025
Region / city: [location/service/organisation]
Topic: Urinary Tract Infection, Nitrofurantoin, PGD (Patient Group Direction)
Document type: PGD (Patient Group Direction)
Organization: UKHSA
Author: Dr. Diane Ashiru-Oredope, Dr. Imran Jawaid, Dr. Kiren Collison, Dr. Naomi Fleming, Mandy Slatter, Jo Jenkins, Kieran Reynolds, Liz Cross, Professor Bhaskar Somani, Temitope Odetunde, Tracy Rogers
Target audience: Registered healthcare professionals authorized by their organization
Effective date: 1st January 2026
Review date: 30th June 2028
Expiry date: 31st December 2028
Approval body: UKHSA HCAI & AMR Division
Document version history: 1.0 (January 2023), 1.1 (July 2023), 1.2 (February 2024), 1.3 (April 2024), 1.4 (January 2025), 2.0 (October 2025)
PGD reviewed by: National UTI antimicrobial PGD Short Life Working Group
Context: This document outlines a Patient Group Direction for the use of nitrofurantoin in the treatment of urinary tract infections, specifying authorized practitioners and legal requirements.
Intrapartum administration of benzylpenicillin sodium for prevention of early-onset Group B Streptococcus (GBS) infection in neonates in [location/service/organisation]
Year: 2025
Region / City: [location/service/organisation]
Topic: Intrapartum administration of benzylpenicillin for GBS prevention
Document Type: Patient Group Direction (PGD)
Organisation: [organisation]
Author: Amy Moore, Christina Nurmahi, Emma Luhr, Felipe Castro Cardona, George Attilakos, Hannah Putley, Janine Elson, Jo Jenkins, Rosie Furner, Sandy Richards, Trixie McAree, Verena Wallace, William Rial, Zoë van Zuylen
Target Audience: Registered healthcare professionals authorised to practice under PGD
Period of Validity: 1st January 2026 - 31st December 2028
Approval Date: 1st January 2026
Review Date: 1st June 2028
Expiry Date: 31st December 2028
Change History: Version 1.0 - January 2023, Version 2.0 - July 2025
Context: This document is a formal guideline for registered healthcare professionals on the use of benzylpenicillin sodium to prevent early-onset GBS infection in neonates.
Distance Approval Cover SheetFor Permanent DL/DH Approval | College of PharmacyCourse Number and Title: PHR 2450 – A tough pill: Health Identity, Disparity, and DiscriminationCarmen Use
Note: Year
FedBizOpps Special Notice - JFASTPAK PILL PACKER MAINTENANCE CONTRACT - VISN14
Year: 2019
Region / City: New York, New Jersey
Subject: Sole Source Contract Award for FastPak Pill Packer Maintenance
Document Type: Contract Notice
Agency / Organization: Department of Veterans Affairs
Author: Kimberly Wiatrowski
Target Audience: Vendors, Contractors
Period of Validity: December 1, 2019 – November 30, 2020
Approval Date: Not specified
Amendment Date: Not specified
Contact Information: Kimberly Wiatrowski, Contract Specialist, [email protected]
Agency URL: www.va.gov
Ozempic 2.0 weight-loss pill could be game-changer
Year: 2023
Region / City: USA
Topic: Weight-loss drugs
Document Type: News article
Organization / Institution: Breaking News English
Author: Not specified
Target audience: General public
Period of validity: Not specified
Approval date: Not specified
Date of changes: Not specified
Requesting repeat Oral contraceptive pill; (annual review)
Note: Year
Topic: Oral contraception, Health review
Document type: Medical form
Organization / institution: South View Partnership
Target audience: Patients requesting repeat oral contraceptive prescriptions
Period of validity: Annual
Biodiversity Self-Assessment Form for Kindlands Major, Bullo Pill, Newnham, August 2024
Year: 2024
Location: Kindlands Major, Bullo Pill, Newnham, Gloucestershire, UK
Document Type: Biodiversity Self-Assessment Form
Relevant Authority: Forest of Dean District Council
Planning Reference: P0948/24/Full
Date Completed: 19/08/2024
Applicable Applications: Householder Full Permission, Outline Permission, Listed Building Consent, Permission in Principle
Related Policies: National Planning Policy Framework (NPPF), Local Planning Authority policies
Protected Features: Local Wildlife Sites, Priority Habitats, Protected and Notable Species
Assessment Scope: Habitats within 100m of the site, existing buildings and trees potentially affecting protected species
Appendices: Biodiversity Guidance for Applications, Appendices 1, 3, 5, 6, 8
Topics: Progestogen-Only locationserviceorganisation pill